ALLISON CLENDENIN: Open Payments
NPI 1649023417 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,427 in 36 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $112 · 2025 $5,427
Travel & lodging: $3,751Food & beverage: $1,634Education: $42
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 11 | $1,840 |
| Medtronic, Inc. | 10 | $1,666 |
| Boston Scientific Corporation | 5 | $1,166 |
| ABBVIE INC. | 4 | $234 |
| Genentech USA, Inc. | 1 | $147 |
| Alexion Pharmaceuticals, Inc. | 1 | $122 |
| Amgen Inc. | 1 | $122 |
| EMD Serono, Inc. | 2 | $114 |
| Lundbeck LLC | 1 | $14 |
Products named: INFINITY, PERCEPT PC BRAINSENSE, General - Therapies, QULIPTA, PROCLAIM, Ocrevus, ULTOMIRIS, UPLIZNA.
Industry payments across MO — which companies pay providers there.
